Bills › 91st General Assembly
Relating to drug paraphernalia
Sponsored by Rep. Brett Barker (R), Rep. Dr. Megan L. Srinivas (D)
Progress
- IntroducedFebruary 20, 2026
- Subcommittee—
- Committee—
- Passed House—
- Passed Senate—
- Signed—
Died at end of session The General Assembly adjourned on May 3, 2026. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
This bill relates to drug paraphernalia. Under current law, a person who knowingly or intentionally manufactures, delivers, sells, or possesses drug paraphernalia commits a simple misdemeanor. Hypodermic needles or syringes manufactured, delivered, sold, or possessed for a lawful purpose are exempt from the definition of “drug paraphernalia”. The bill also exempts equipment, products, or materials used to analyze or test for the presence of fentanyl, a fentanyl analog, or a drug adulterant within a controlled substance from the definition of “drug paraphernalia”.
From the explanation printed with the bill as introduced, written by the Legislative Services Agency. Amendments adopted later aren’t reflected. Full bill text
History
Votes
No recorded votes yet.
Lobbyist declarations
Grouped by organization. Lobbying overview →